Samuel G. Armato to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Samuel G. Armato has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.422
-
Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1). J Thorac Oncol. 2018 07; 13(7):1012-1021.
Score: 0.315
-
Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma. J Thorac Oncol. 2013 Apr; 8(4):478-86.
Score: 0.055
-
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J Clin Oncol. 2012 Jul 10; 30(20):2509-15.
Score: 0.052